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1. Introduction 
Branched-chain 2-oxoacid dehydrogenase complex 
activity is low in freshly prepared rat heart mitochon- 
dria as compared with rat liver or bovine kidney or 
liver rnitochondria [l-4]. The low activity of the 
heart complex is apparently due to reversible inactiva- 
tion by MgATP [ 11. Thus activity of the complex is 
increased up to 20-times when heart mitochondria are 
depleted of ATP by incubation witllout respiratory 
substrate or with uncouplers of respiratory chain 
phosphorylation. Low activities persist in mitochon- 
dria incubated with respiratory substrates. Active 
complex in extracts of mitochondria is inactivated by 
incubation with MgATP; this inactivation is prevented 
by branched-chain 2-oxoacids and branched-chain 
2-oxoacids reactivate the complex in rat heart mito- 
chondria [I]. Purified bovine kidney complex is not 
inactivated by MgATP [4]. These observations sug- 
gested that there are interconvertible active and 
inactive forms of the complex in rat heart but not in 
rat liver or kidney or bovine kidney. Evidence is 
given here for inactivation of branched-chain complex 
in rat heart and skeletal muscle mitochondria by ATP; 
for reactivation of inactive complex in extracts of 
heart mitochondria by preparations of pyruvate 
dehydrogenase phosphate phospllatase; for intercon- 
vertible active and inactive forms of the complex in 
Ab&zviafions: TPP, thiamin pyrophosphate; OIC, 2_oxoiso- 
caproate (4-methyl, 2+xopentanoate); TLCK,N-a-p-tosyl-l- 
&sine chloromethyl ketone; CCCP, carbonyl cyanide m-chloro. 
phenyl~ydrazoxle; DTT, dithiothreitoi; EGTA. ethanedioxybis- 
(ethylamine)-tetra cetate 
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perfused rat heart; and for absence of complex inacti- 
vation by ATP in rat liver or kidney mitochondria. 
2. Experimental 
Sources of biochenlicals and chemicals are given in 
[l-3]. Pyruvate dehydrogenase phosphate phospha- 
tase was partially purified from ox-hearts [5]. Rat 
heart lllitocllondr~a were prepared with Nagarse 161; 
rat psoas muscle mitochondria were prepared as in 
[7]. Rat kidney mitochondria were prepared as in 
f8]; rat liver r~litochorldria were prepared by the same 
method except that the first mitochondrial pellet was 
incubated for 2 min at 4°C with digitonin (1 mg/ml; 
5 ml/liver) to remove lysosomes 191. 
Rat hearts were perfused by drip through [lo] at 
38°C with bicarbonate-buffered saline saturated with 
95% 02/5% CO,; for other additions and time of 
perfusion see section 3.4. Hearts were frozen with a 
tissue clamp at Iiquid N2 temperature and powdered 
under liquid Nz with a pestle and mortar, After warm- 
ing to -10°C powder from each heart was extracted 
into 5 ml 30 mM potassium ph~)sphate~3 mM EDTA/ 
5 mM DTTiO.5 mM OIC/l mM TLCK/S% (v/v) 
Triton X-lOO/pH 7.5 by vortex-mixing and freezing 
(liquid N2) and thawing (30°C) 3 times. The extracts 
were centrifuged (2°C) at 33 000 X g for 5 min to 
remove debris; the supernatants were then centrifuged 
at 180 000 X g for 90 mm to concentrate the branched- 
chain complex. The pellets containing the pyruvate, 
2-oxoglutarate and branched-chain 2-oxoacid dehy- 
drogenase complexes were each taken up in 0.5 ml 
30 mM potassium phosphate/S mM DTT/pH 7.5 with 
an all glass Potter-Elvehjem homogeniser. 
Mitochondria were incubated in Eppendorf cen- 
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trifuge tubes at 30°C in KC1 medium [IO] (1-4 mg OIC (8 obs.; 6 cont. from S-200 PM); 10.6 + 2.3 ,uM 
protein/ml), separated by centrifugation and frozen CoA (8 obs.; 6 cont. from 12.5-400 PM); 
as in [lo]. Extracts were prepared by freezing and 40.0 + 5.7 @I NAD‘(8 ohs.; 6 cone. from 3 1.25 PM- 
thawing in extraction medium containing (unless I mM). These values are close to those for rat liver 
stated) 5% Triton X-100 as in [ 11. complex [ 31. 
Branched~ha~ 2-oxoacid dehydro~~nase complex 
activity was assayed in extracts of rat heart or mito- 
chondria as the initial rate of NAD’ reduction at 3O”C, 
measured spectrophotometrically at 340 nm. Assay 
buffer and conditions of assay were as in [I]. A blank 
correction was subtracted (rate of aEa, in the 
absence of OIC measured concurrently). Pyruvate and 
2oxoglutarate dehydrogenase complex activities were 
assayed by the same method but with 1 mM.nyruvate 
or 1 mM 2oxoglutarate. Rates were proportronal to 
volume of extract and constant for -1 min. Citrate 
synthase activity was assayed as in [IO]. 
3.2. Effect of in tramitochondrial A TP concentration 
on activi[y of branched-chain 2-oxoacid dchy- 
droge~se ~orrlpiex in rat hearty psoas muscle, 
liver and kidney mitochondria 
Freshly prepared rat heart mitochondria have low 
A unit of enzyme activity forms I jrrmol product/ 
min at 30°C. Values of Km were computed as in [ 1 l] 
and concentrations of free Mg2’ and Ca” as in [S]. 
The proportion of branched-chain complex in the 
active form was calculated as follows. Assays in 
extracts of perfused heart gave the activity ratio of 
(active branched-chain complex)/(:!-oxoglutarate 
dehydrogenase complex) (A). Assays in extracts of 
mitochondria incubated for 1.5 mm at 30°C (to effect 
conversion of inactive complex into active complex) 
gave the activity ratio (total branched-chain complex)/ 
(2~xogIutarate dehydrogenase complex) (3). The % 
of active complex was calculated as 100 A/B. This 
method was chosen because conversion of inactive 
complex to active complex in heart extracts has not 
been satisfactorily achieved. The 2-oxoglutarate 
dehydrogenase complex was used as marker enzyme 
because it cosedimented with the branched-chain 
complex in a linear 5 -20% (w/v) sucrose gradient 
(not shown) and because it does not exist in active 
and inactive forms. The method assumes equivalent 
recoveries of the two complexes. 
branched~hain complex activity which persists on 
incubation with respiratory substrate (e.g., 5 mM 
succinate) [ 11. Activity is increased up to 20 times 
by depletion of mitocholldrial ATP (uncouplers or 
incubation at 30°C without substrate) or incubation 
with OIC [ 11 or 3-methyl-2-oxopentanoate or 
3-methyL2oxobutyrate (P.J.P., P.J.R., unpubIislied). 
As shown in table 1 (lines 1-3) the activity of the 
branched-chat complex in rat heart mitochondria 
was reduced to 2% by extramitochondrial ATP under 
conditions where ATP may enter mitochondria in 
exchange for ADP(presence of oligomycin and CCCP). 
This effect of external ATP was blocked by 0.5 mM 
OIC. In these experiments the complex was activated 
by 10 min of pre-incubation in KC1 medium with 
oligomycin i- CCCP before additions of ATP + OIC. 
In rat psoas muscle mitochondria incubated with 
5 mM succinate, branched~ha~l complex activity was 
increased L/-fold by 10 PM 2,4-dinitrophenol (table 1, 
lines 4-7). This observation supports the suggestion 
that the rat skeletal muscle complex [ 121 like rat 
heart complex is inactivated by ATP. 
3. Results and discussion 
3 .I . K,,, values for rat heart bran~hed~ha~n Z-oxoacid 
dehydrogenase complex 
These experiments were made with extracts of 
mitochondria incubated in bulk at 30°C for 15 min 
in KC1 medium, separated by centrifugation (5 min, 
33 000 X g), frozen, and extracted as in section 2. 
The Km values were (mean rt SEM) 14.5 f 6.0 PM 
The activity of branched-chain complex in rat liver 
mitochondria incubated with oligomycin and CCCP 
was not decreased by ATP; the activity of the pyruvate 
dehydrogenase complex in the same experiment was 
decreased to 22% of the control by ATP (table I, 
lines S-9). In rat liver mitochondria (lines 10,ll) or 
rat kidney mitochondria (lines 12,13) incubated with 
5 mM succinate, 10 PM 2,4-d~itrophenol did not 
increase branched-chain complex activity. Pyruvate 
dehydrogenase complex activity measured under the 
same conditions increased with dinitrophenol3.5 times 
in liver mitochondria and 3.2 times in kidney mito- 
chondria. These results indicate that rat liver and rat 
kidney branched-chain 2-oxoacid dehydrogenase com- 
plexes are not inactivated by ATP in mitochondria in 
contradistinction to results with rat heart and rat 
psoas muscle mitochondria. 
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Table 1 
Effect of external ATP, or of succinate or 2,4dinitrophenol on activities of branched-chain 
2oxoacid and pyruvate dehydrog~nase complexes in rat heart, psoas, liver and 
kidney mitochondria 
April 1980 























+ 10 ,uM-2,4- 
dinitrophenol 
Activity; mean L SRM in munits complex/unit citrate 
synthase 
~___~_ 
Branched~llain 2oxoacid Pyruvate dehydrogenase 
dehydrogenase complex complex 
1.67 -t O&6* (3)b - 
0.03 !z 0.03 (3)b - 
1.39 i- 0.03* (3)b - 
0.16 t 0.04* (20) 
0.15 c O.lO* (8)” -- 
0.21 t 0.05* (ll)b - 
1.13 i 0.06 (19)b 
31.0 +_ 0.7 (3)a 129.0 i. 3.6 (3)a 
30.5 * 1 .4 (3Yt 29.7 i 2.4* (3)a 
15.0 i: 2.2 (3)a 14.7 + 4.2 (3)a 
15.8 L 0.8 (3)a 101.0 + 2.4* (3)a 
7.9 2 0.80 (3)b 40.2 + 4.2 (3)b 
7.1 t 0.59 (3)b 129.4 f 2.0* (3)b 
Rat heart *P < 0.01 against 5 mM ATP; psoas *P < 0.01 against 2,4dinitrophenol; liver 
*P < 0.01 for effect of ATP,and of 2,4din~trophenol; kidney *P < 0.01 for effect of 
2,4dinitrophenol 
Mitochondria were incubated in KC1 medium (see section 2) at 30°C for 5 mina or 10 minb 
with additions as shown, separated by centrifugation, frozen and extracted. Extracts were 
assayed for branched-chain 2-oxoacid and pyruvate dehydrogenase activities and citrate 
synthasc activity. In experiments in which effects of ATP addition were studied, KC1 
medium contained EDTA in place of EGTA and additionally 10 PM CCCP and oligomycin 
(25 #g/ml). In experiments with rat heart mitocilondria only, mitocilondria were preincubated 
in KC1 medium for IO ntin at 30°C before making additions as shown and commencing 
~cubation. For details of ~?reparation f mitochondria, composition of KCI medium and 
extraction and assays ee section 2. No. obs. in parentheses 
3.3. ~~a~~~~~~~~n o~i~act~~e rat heart ~ra~c~ed-c~ai~~ 
2-oxoacid dehyd~o~enase complex by partial& 
budged ox&art pymvate dehyd~o~er~ase phos- 
phate phosphatase 
Reactivation of inactive rat heart mitochondria~ 
branched-chain complex by a preparation of ox-heart 
pyruvate dehydrogenase phosphate phosphatase is 
shown in fig.1, In {a) inactive complex was obtained 
by extracting freshly prepared rat heart mitochondria. 
In these mitochondria -30% of complex was inactive 
(based on reactivation by 12 mm incubation at 30°C 
in KC1 medium). Complete reactivationof the complex 
in extracts was achieved by 20-25 min il~cubation 
with phosphatase in the presence of MgClz (free Mg2*, 
1.3 mM) and CaEGTA buffer (free Ca2*, 13.6 PM). 
No reactivation was seen in the absence of phospha- 
tase, or in the absence of Mg2+ and at very low Ca2* 
(absence of Mgf&; 10 mM EDTA; computed Ca’+, 
0.08 PM). Active complex,in extracts of preincubated 
mitochondria showed a smaI1 activation with phos- 
phatase and no change of activity in the absence of 
phosphatase. 
In fig.1 (b) inactive complex was obtained by 
incubating extracts of rat heart mitochondria (in 
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Fig.1. Branched-chain 2-oxoacid ehydrogenase complex 
activity in extracts of rat heart mitochondria. 
(a) Closed symbois extracts of freshly prepared mitochon- 
dria. Open symbols, extracts of mitochondria incubated for 
12 mm at 30°C in KC1 medium without respiratory substrate. 
Extracts prepared in medium without Triton X-l 00 (see sec- 
tion 3.3). Extracts (13.4 mg protein/ml) were incubated at 
30°C with the following additions after 2 min (arrows); (o,*) 
none; (A+) MgSO, to 10 miM + 0.1 vol. ox-heart pyruvate 
dehydrogenase phosphatase; (=) MgSO, to 10 mM, (9) EDTA 
to 10 mM + 0.1 vol phosphatase. Samples were taken for 
assay of branchedchain 2+xoacid dehydrogenase complex at 
times shown; in these experiments assay buffer (see section 2) 
contained 5% (v/v) Triton X-100. Each point is mean of 2 obs. 
(b) Freshly prepared rat heart mitochondria (A) were pre- 
incubated for 12 mm at 30°C in KC1 medium without 
respiratory substrate. Extracts (21.2 mg protein~m1) were 
then prepared in medium without Triton X-l 00 (see section 2) 
and (a) incubated for 20 mm at O’C with 0.3 mM ATP; then 
0.1 vol. (100 mM EGTA, 99 mM CaCl,, 100 mM MgSO,, 
2 mM TPP, 5 mM OIC) added and the incubation mixture 
incubated at 3O’C for 2 min. Pyruvate dehydrogenase phos- 
phatase (0.1 vol.) was then added (arrow). Each point is 
mean of 2 obs. 
which complex had been activated by preincubation) 
with 0.3 mM ATP for 20 min at 0°C (the Mg2+ 
required for this reaction was derived from the mito- 
chondria). After warming to 30°C addition of phos- 
phatase + MgClz t CaEGTA buffer (Mg’+ and Ca2* 
concentrations as in fig.1 (a)) plus OIC to 0.5 mM 
(to inhibit the inactivation reaction [l]) led to com- 
plete reactivation within 15 min. No reactivation was 
seen in the absence of phosphata~ (not shown). 
In these experiments mitochondrial extracts were 
made in 30 mM potassium phosphate/5 mM DTT/ 
1 mM TLCK/O.2 mM TPP/lO mM EGTA/9.9 mM 
CaClJpH 7.5 (fig.1 (a)); or 30 mM potassium phos- 
phate/5 mM DTTjl mM TLCK/pH 7.5 (fig.1 (b)); 
with other additions as in (a) after 20 min incubation 
with ATP). The active branched-chain complex is 
stable on incubation at 30°C under these conditions 
because of the absence of Triton (cf. [I]). Stability 
was improved with TPP (not shown). 
These results show that an ox-heart pyruvate 
dehydrogenase phosphate phosphatase preparation 
converted inactive branched-chain 2-oxoacid dehy- 
drogenase complex into the active form under con- 
ditions (i.e., presence of Mg” and Ca23 which leads 
to conversion of pyruvate dehydrogerlase phosphate 
complex into its active (dephosphorylated) form 1131. 
3.4. Proportion of active branched-chain 2-oxoacid 
dehydrogenase complex in perfused rat heart 
These data are shown in fig.2. In hearts of fed nor- 
mal rats -13% of branched-chap complex was in the 
I I J 
0 5 
min of perfusion 
10 
Fig.2. Branched~ha~ 2-oxoacid dehydrogenase complex 
activity in perfused rat heart. Hearts of fed normal rats were 
perfused by drip through at 38’C with bicarbonate-buffered 
saline gassed with (O,/CO,: 9S/5) and containing; (o) 5 5 mM 
glucose; (A) 5 5 mM glucose + 50 I.~M OIC; (n) S .S mM 
glucose + 0.5 mM OIC. At the times shown the heart was 
clamped at liquid N, temperature, powdered under liquid 
N, and extracted and processed as in section 2. The activities 
of branched~h~n Zoxoacid (active form) and 2oxoglutarate 
dehydrogenase complexes were assayed and the % of active 
complex calculated as in section 2. Each point is mean of 
3 obs. The total activity of the branchedchain complex was 
0.16 units/g wet wt of heart. 
tP < 0.05 against zero time. *P < 0.01 against (0). 
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active form; this decreased to -6% after 10 min per- 
fusion with 5 mM glucose. The proportion of active 
complex was increased when OIC was present in addi- 
tion to glucose to reach 50% (50 PM OIC; 10 min 
perfusion) or 77%(500/*M OIC; 5 or 10 min perfusion). 
With 0.5 mM L-leucine t 5.5 mM glucose the propor- 
tion of active complex was 22.6% (at 6 min; not 
shown;l’<0.02 against glucose alone). The proportion 
of active complex was thus increased by OIC and by 
leucine, its precursor in vivo. These results would 
appear to show that inactivation of the complex by 
ATP occurs in vivo; that this inactivation is inhibited 
by OIC in vivo; and that reactivation occurs in vivo. 
The highest tots1 activity of branched chain com- 
plex in rat heart das 0.30 unit/g wet wt measured at 
30°C (assuming 80 mg mitochondrial protein/g wet 
wt). Rat heart perfused with L-leucine at 38°C shows 
oxidation rates of the amino acid which are approx- 
imately proportional to perfusate concentration up to 
a maximum of 0.12 pm01 . min-‘. g wet wt-’ at 
1 mM [ 141. It may thus be inferred that the rate of 
oxidation was 0.06 ,umol . min-‘. g-’ at 0.5 mM. Our 
estimates of branched-chain complex activity 
(0.07 unit at 30°C with 0.5 mM L-leucine) may thus 
be consistent with measured rates of leucine oxida- 
tion in the perfused heart at 38°C. 
3.5 . General discussion 
In first describing interconvertible active and 
inactive forms of the branched-chain complex in rat 
heart mitochondria and inactivation by ATP [I] we 
were unable to show reactivation in mitochondrial 
extracts. This has been accomplished here by adding 
a preparation of ox-heart pyruvate dehydrogenase 
phosphate phosphatase and by defining conditions 
where branchedchain complex in extracts of mito- 
chondria is stable at 30°C. This evidence, in conjunc- 
tion with the observation that non-phosphorylating 
analogues of ATP do not inactivate the complex in 
extracts of skeletal muscle [ 121 or rat heart mito- 
chondria (PJ.P., PJ.R., unpublished), suggests 
strongly that inactivation is due to phosphorylation. 
We have shown further that active and inactive forms 
of the complex are present in heart in vivo; and that 
OIC (and its precursor leucine) effect conversion of 
inactive complex into active complex. The intercon- 
version may therefore be of physiological significance. 
This study and [ 1,4,12] indicate that intercon- 
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vertible active and inactive forms of the complex are 
present in heart and skeletal muscles but not in liver 
or kidney mitochondria. This provides for the possi- 
bility of differential regulation of branched-chain 
amino acid oxidation in muscle as compared with 
liver and kidney. This could, for example, be related 
to their unique capacity to form glucose (liver and 
kidney) or ketone bodies (liver) from individual 
branched-chain amino acids. There may be mecha- 
nisms whereby branched-chain amino acids may 
either be directly oxidised in the periphery or indi- 
rectly through formation of ketone bodies and glu- 
cose in liver (and kidney). These questions may be 
answered by regional measurements of clearance 
rates of branched-chain 2-oxoacids in vivo. 
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